American Society of Hematology

SHERPA: Blue

People

  1. Mauro
    Mauro
  2. Berman
    Berman
  3. Levine
    Levine
  4. Rampal
    Rampal

Groups

  1. Adult Leukemia (7)
  2. Center for Hematologic Malignancies (7)
  3. Department of Medicine (7)
  4. Hematologic Malignancies, Division of (7)
  5. Alumni (GSK) (1)
  6. Executive Committee, Center for Hematologic Malignancies (1)
  7. GSK Faculty (1)
  8. Gerstner Sloan Kettering Graduate School of Biomedical Sciences (1)
  9. Human Oncology and Pathogenesis Program (1)
Search Within
  1. "Center for Hematologic Malignancies"
  2. "Michael Mauro"
  3. "Blood"
  4. "2015"
Formats
  1. Meeting Abstract (7)
Groups
  1. Adult Leukemia (7)
  2. Center for Hematologic Malignancies (7)
  3. Department of Medicine (7)
  4. Hematologic Malignancies, Division of (7)
  5. Alumni (GSK) (1)
  6. Executive Committee, Center for Hematologic Malignancies (1)

More Groups

People
  1. Michael Mauro (7)
  2. Anna Mckenney (1)
  3. Ellin Berman (1)
  4. Jihae Ahn (1)
  5. Martin Tallman (1)
  6. Raajit Rampal (1)

More People

Years
  1. 2015 (7)
Publications
  1. Blood (7)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Rapid achievement of MR(4.5) after switching from imatinib (IM) to nilotinib (NIL) in patients (Pts) with chronic myeloid leukemia in chronic phase (CML-CP): Preliminary results from ENESTgoal
    Meeting Abstract

    Ritchie, E. K.; Catchatourian, R.; Klisovic, R. B.; Deininger, M. W.; Erba, H. P.; Radich, J. P.; Savona, M. R.; Warsi, G.; Paley, C. S.; Dautaj, I.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Clinical evaluation of Xpert(R) BCR-ABL Ultra, an automated and standardized cartridge-based assay for the quantification of BCR-ABL1
    Meeting Abstract

    Mauro, M. J.; Press, R. D.; Snyder, D. S.; Huang, Q.; Pinilla-Ibarz, J.; Qin, D. H.; Lockwood, C.; Payton, J. E.; Uy, G. L.; Kalaycio, M. E.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • AUY922, a Heat Shock Protein 90 (Hsp90) inhibitor, demonstrates activity in patients with myeloproliferative neoplasms (MPNs)
    Meeting Abstract

    Hobbs, G.; Litvin, R.; Ahn, J.; McKenney, A. S.; Mauro, M. J.; Tallman, M. S.; Berman, E.; Heaney, M. L.; Levine, R. L.; Rampal, R. K.
    Blood (2015)

    Fulltext@MSK | Save
  • ENESTnext final results: Deep molecular response (MR) with nilotinib (NIL) in patients (pts) with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP)
    Meeting Abstract

    Berdeja, J. G.; Heinrich, M.; Dakhil, S.; Goldberg, S. L.; Wadleigh, M.; Catchatourian, R.; Kuriakose, P.; Cortes, J. E.; Radich, J. P.; Rizzieri, D. A.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • ABL001, a potent, allosteric inhibitor of BCR-ABL, exhibits safety and promising single- agent activity in a phase I study of patients with CML with failure of prior TKI therapy
    Meeting Abstract

    Ottmann, O. G.; Alimena, G.; DeAngelo, D. J.; Goh, Y. T.; Heinrich, M. C.; Hochhaus, A.; Hughes, T. P.; Mahon, F. X.; Mauro, M. J.; Minami, H.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • The impact of ponatinib versus allogeneic stem cell transplant (SCT) on outcomes in patients with chronic myeloid leukemia (CML) or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph plus ALL) with the T315I mutation
    Meeting Abstract

    Nicolini, F. E.; Basak, G. W.; Kim, D. W.; Olavarria, E.; Pinilla-Ibarz, J.; Apperley, J. F.; Hughes, T. P.; Niederwieser, D.; Mauro, M. J.; Chuah, C.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Real-world ponatinib prescribing patterns and outcomes in US patients
    Meeting Abstract

    Mauro, M. J.; McGarry, L. J.; Yang, M.; Lustgarten, S.; Huang, H.
    Blood (2015)

    Fulltext@MSK | Save